A phase I study of combination adjuvant immunotherapy for patients with resectable hepatocellular carcinoma
Phase 1
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000029991
- Lead Sponsor
- Yamaguchi University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Uncontroled general complication. etc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety
- Secondary Outcome Measures
Name Time Method 1)specific CTL response in PBMC 2)specific CTL response in the tumor 3)relapse-free survival 4)overall survival